Medigus Ltd. WT C EXP 072... (MDGSW)
Medigus WT C EXP 072323 Statistics
Share Statistics
Medigus WT C EXP 072323 has - shares outstanding. The number of shares has increased by null% in one year.
| Shares Outstanding | - |
| Shares Change (YoY) | n/a |
| Shares Change (QoQ) | n/a |
| Owned by Institutions (%) | n/a |
| Shares Floating | - |
| Failed to Deliver (FTD) Shares | - |
| FTD / Avg. Volume | < 0.01% |
Short Selling Information
| Short Interest | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Valuation Ratios
The PE ratio is 0 and the forward PE ratio is null. Medigus WT C EXP 072323's PEG ratio is 0.
| PE Ratio | 0 |
| Forward PE | n/a |
| PS Ratio | 0 |
| Forward PS | null |
| PB Ratio | 0 |
| P/FCF Ratio | 0 |
| PEG Ratio | 0 |
Enterprise Valuation
Currently the Enterprise Value (EV) is not available for Medigus WT C EXP 072323.
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 1.39, with a Debt / Equity ratio of 0.26.
| Current Ratio | 1.39 |
| Quick Ratio | 1.34 |
| Debt / Equity | 0.26 |
| Debt / EBITDA | -0.85 |
| Debt / FCF | -1.77 |
| Interest Coverage | 3.38 |
Financial Efficiency
Return on Equity is n/a and Return on Invested Capital is n/a.
| Return on Equity | n/a |
| Return on Assets | n/a |
| Return on Invested Capital | n/a |
| Revenue Per Employee | $- |
| Profits Per Employee | $- |
| Employee Count | undefined |
| Asset Turnover | 0.94 |
| Inventory Turnover | 43.22 |
Taxes
| Income Tax | 111K |
| Effective Tax Rate | -1.1% |
Stock Price Statistics
The stock price has increased by null% in the last 52 weeks. The beta is 0, so Medigus WT C EXP 072323's price volatility has been lower than the market average.
| Beta | 0 |
| 52-Week Price Change | null% |
| 50-Day Moving Average | 0.06 |
| 200-Day Moving Average | 0.16 |
| Relative Strength Index (RSI) | 43.71 |
| Average Volume (20 Days) | - |
Income Statement
In the last 12 months, Medigus WT C EXP 072323 had revenue of 91.86M and earned -10.21M in profits. Earnings per share was 0.
| Revenue | 91.86M |
| Gross Profit | 14.45M |
| Operating Income | -13.78M |
| Net Income | -10.21M |
| EBITDA | -11.99M |
| EBIT | -14.18M |
| Earnings Per Share (EPS) | 0 |
Balance Sheet
The company has 20.07M in cash and 10.13M in debt, giving a net cash position of 9.93M.
| Cash & Cash Equivalents | 20.07M |
| Total Debt | 10.13M |
| Net Cash | 9.93M |
| Retained Earnings | -85.59M |
| Total Assets | - |
| Working Capital | - |
Cash Flow
In the last 12 months, operating cash flow was -5.66M and capital expenditures -74K, giving a free cash flow of -5.73M.
| Operating Cash Flow | -5.66M |
| Capital Expenditures | -74K |
| Free Cash Flow | -5.73M |
| FCF Per Share | 0 |
Margins
Gross margin is 15.73%, with operating and profit margins of -15.01% and -11.11%.
| Gross Margin | 15.73% |
| Operating Margin | -15.01% |
| Pretax Margin | -10.99% |
| Profit Margin | -11.11% |
| EBITDA Margin | -13.05% |
| EBIT Margin | -15.01% |
| FCF Margin | -6.24% |
Dividends & Yields
MDGSW does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Payout Ratio | n/a |
| Earnings Yield | n/a |
| FCF Yield | n/a |
Analyst Forecast
Currently there are no analyst rating for MDGSW.
| Price Target | n/a |
| Price Target Difference | n/a |
| Analyst Consensus | n/a |
| Analyst Count | n/a |
Scores
| Altman Z-Score | null |
| Piotroski F-Score | null |